Nasty or Nice? A Perspective on the Use of Health Technology Assessment in the United Kingdom

被引：28

作者：

Drummond, Michael ^{[1
]}

Sorenson, Corinna ^{[2
]}

机构：

[1] Univ York, Ctr Hlth Econ, York YO1O 5DD, N Yorkshire, England

[2] London Sch Econ, LSE Hlth & Social Care, London WC2A 2AE, England

来源：

VALUE IN HEALTH | 2009年 / 12卷

关键词：

health technology assessment; HTA; National Institute for Clinical Excellence; NICE; United Kingdom; CLINICAL EXCELLENCE; NATIONAL INSTITUTE; DECISION-MAKING; GUIDANCE; NHS; OFT;

D O I：

10.1111/j.1524-4733.2009.00552.x

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

[No abstract available]

引用

页码：S8 / S13

页数：6

共 29 条

[1]

[Anonymous], 1996, Cost-effectiveness in health and medicine

[2]

[Anonymous], SOC VAL JUDG

[3]

[Anonymous], 2006, GUID EC EV HLTH TECH, V3rd

[4]

[Anonymous], 2007, PHARM PRIC REG SCHEM

[5]

[Anonymous], 2008, Guide to the methods of technology appraisal

[6]

*AUD COMM, 2005, MAN FIN IMPL NICE GU

[7]

BARBIERI M, 2007, HLTH EC STUD GROUP M

[8] Who Does the Numbers? The Role of Third-Party Technology Assessment to Inform Health Systems' Decision-Making about the Funding of Health Technologies [J].

Barbieri, Marco ;

Hawkins, Neil ;

Sculpher, Mark .

VALUE IN HEALTH, 2009, 12 (02) :193-201

[9] Information created to evade reality (ICER) - Things we should not look to for answers [J].

Birch, Stephen ;

Gafni, Amiram .

PHARMACOECONOMICS, 2006, 24 (11) :1121-1131

[10]

BUXTON M, 1985, COSTS BENEFITS HEART

← 1 2 3 →